טוען...
Rapalogs and mTOR inhibitors as anti-aging therapeutics
Rapamycin, an inhibitor of mechanistic target of rapamycin (mTOR), has the strongest experimental support to date as a potential anti-aging therapeutic in mammals. Unlike many other compounds that have been claimed to influence longevity, rapamycin has been repeatedly tested in long-lived, genetical...
שמור ב:
Main Authors: | , , , |
---|---|
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
American Society for Clinical Investigation
2013
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3582126/ https://ncbi.nlm.nih.gov/pubmed/23454761 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI64099 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|